Jefferies cuts Kratos Defense stock price target on cash flow outlook

Jefferies cut Kratos Defense's price target to $68 from $80 while retaining a Buy rating, forecasting free-cash-flow use of $99 million in FY2026 and $14 million in FY2027 as the company funds capacity expansion ahead of production ramps. The firm nonetheless projects 19% revenue growth and 31% EBITDA growth in 2027, supported by hypersonics and propulsion operations representing 23% of sales. Kratos's recent Q2 revenue rose 30% year over year to about $459 million, adjusted EBITDA increased 43% to $38.2 million, and adjusted EPS of $0.21 exceeded the $0.16 consensus; the company also raised its organic-growth outlook for Q3 and Q4.

Analysis

KTOS is entering the valuation-sensitive phase common to defense disruptors: investors must underwrite a multi-year conversion of backlog and prototype activity into repeatable, higher-margin production rather than simply award a premium for exposure to autonomous systems and missile defense. The key near-term issue is not demand visibility but cash conversion; sustained negative free cash flow can force the market to value KTOS on revenue growth while discounting EBITDA as non-cash until utilization improves. That creates a wider-than-normal multiple range and makes quarterly capex, inventory, and milestone-payment timing more important than headline sales beats.

The second-order beneficiary of capacity investment is strategic relevance with the DoD: companies able to self-fund production readiness may gain share from slower-prime procurement models, but that advantage only materializes if programs move from development to funded lots. AVAV and RCAT remain cleaner public proxies for unmanned-system budget growth, while larger primes such as LMT and RTX offer lower-duration exposure to the same budget pool. A budget delay, continuing resolution, or a shift toward competing platforms could hurt KTOS disproportionately because fixed-cost absorption is central to the forward margin case.

Consensus appears focused on the growth runway but may be underpricing the financing/working-capital bridge required before scale economics arrive. The stock can work over 6-18 months if operating cash flow inflects ahead of modeled profitability; over the next 1-3 months, however, execution disclosures matter more than another revenue upside. Falsify the constructive view if management extends the cash-burn period, raises capacity spending without corresponding funded awards, or fails to demonstrate sequential gross-margin and working-capital improvement.

Key Decisions for Investors

• Maintain KTOS as a watch-to-buy rather than chase: initiate only after the next earnings release confirms funded-production conversion and no incremental deterioration in the forward free-cash-flow bridge. Target a 6-18 month holding period; exit if management pushes expected cash-flow breakeven out by more than two quarters.
• For defense-growth exposure over the next 1-3 months, prefer a pair of long KTOS / short a diversified defense ETF such as ITA only if KTOS underperforms on the cash-flow reset while award visibility remains intact. This isolates execution upside from broad defense-budget and rate-risk; size modestly because KTOS-specific volatility will dominate.
• Use a post-results catalyst framework: add only if sequential gross margin, operating cash flow, and production-capacity utilization improve together. A revenue beat funded by inventory build or unfavorable milestone timing is not a buy signal.
• Avoid long-dated calls until implied volatility and the company’s cash-spend trajectory are reviewed; the missing inputs are current option skew, net cash/debt, and management’s capex/working-capital cadence. If those data show liquidity pressure rather than temporary investment, the appropriate trade is no position rather than a directional short.